STAT6-IP reduces the development of allergic-type lung inflammation and airway hyperresponsiveness
Scientists discover peptide that could reduce the incidence of RSV-related asthma.
Faculty
View recent posts and news from our faculty members. For our faculty profiles, read more here: https://meakinsmcgill.com/faculty-members/
Desensitization program helps kids with milk allergies
New study is helping children with milk allergies build up tolerance to milk protein
Newborn screening for Cystic Fibrosis patients
New study sheds light on the importance of newborn screening for Cystic Fibrosis patients
Educating the immune system with SAT6-IP
Potential vaccine redirects the immune response away from developing allergies
Bacteria and Inflammation in Cystic Fibrosis
New publication showing Pseudomonas variants in Cystic Fibrosis.
Learning Early about Peanut Allergy
New trial is changing how we approach peanut allergies.
Accelerating new treatments for respiratory diseases
Dr. Basil Petrof talks with the CFI about accelerating respiratory disease treatments
Patients Referred to Neurologists with Respiratory Symptoms: Is it Pompe Disease?
About Pompe Disease: Podcast with Dr. Basil Petrof
PGE2 inhibition increases survival of mice infected with H1N1 flu virus
New study by Maziar Divangahi show that PGE2 inhibition increases survival to the flu in mice
Pseudomonas aeruginosa and biofilms: new insights on antibiotic tolerance
Pseudomonas aeruginosa develop a response to starvation, allowing them to better adapt and survive.
- « Previous
- 1
- …
- 14
- 15
- 16